Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-14-080518
Filing Date
2014-03-03
Accepted
2014-03-03 17:09:53
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A d681125d10qa.htm 10-Q/A 525575
2 EX-31.1 d681125dex311.htm EX-31.1 5940
3 EX-31.2 d681125dex312.htm EX-31.2 5977
4 EX-32.1 d681125dex321.htm EX-32.1 3277
5 EX-32.2 d681125dex322.htm EX-32.2 3581
  Complete submission text file 0001193125-14-080518.txt   4579607

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbrx-20130930.xml EX-101.INS 593946
7 XBRL TAXONOMY EXTENSION SCHEMA cbrx-20130930.xsd EX-101.SCH 50844
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbrx-20130930_cal.xml EX-101.CAL 83601
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbrx-20130930_def.xml EX-101.DEF 143049
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbrx-20130930_lab.xml EX-101.LAB 358687
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbrx-20130930_pre.xml EX-101.PRE 269371
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-10352 | Film No.: 14661347
SIC: 2834 Pharmaceutical Preparations